The National Antimicrobial Resistance Monitoring System (NARMS) was established in 1996. NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA). This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States. The NARMS program helps promote and protect public health by providing information about emerging bacterial resistance, how resistant infections differ from susceptible infections, and the impact of interventions designed to limit the spread of resistance. NARMS data are used by FDA to make regulatory decisions designed to preserve the effectiveness of antibiotics for humans and animals.
- Twenty Years of the National Antimicrobial Resistance Monitoring System (NARMS) - What Have We Learned So Far and What Is Next?
A presentation by Patrick McDermott, Director of NARMS at Combating Antimicrobial Resistance: A One Health Approach to a Global Threat—A Workshop. The National Academy of Sciences Engineering and Medicine. June 2017.
- NARMS 20th Anniversary Timeline
- NARMS Program Facts
November 22, 2019 - FDA Releases 2016-2017 NARMS Integrated Summary, Streamlines Reporting Format
October 23, 2017 - FDA Releases 2015 NARMS Integrated Report